1,810
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Immunotoxic effects of gold and silver nanoparticles: Inhibition of mitogen-induced proliferative responses and viability of human and murine lymphocytes in vitro

, &
Pages 897-902 | Received 24 Jan 2016, Accepted 06 Sep 2016, Published online: 18 Oct 2016

Figures & data

Figure 1. Size distribution and particle concentration. Measurements obtained using NTA. (A) GNP. (B) SNP. Graph presented is representative of four independent experiments. x-axis: diameter (nm); y-axis: particle number (×106/ml).

Figure 1. Size distribution and particle concentration. Measurements obtained using NTA. (A) GNP. (B) SNP. Graph presented is representative of four independent experiments. x-axis: diameter (nm); y-axis: particle number (×106/ml).

Table 1. Distribution of size and number determined by NTA.

Figure 2. Effects of NP on mouse splenic lymphocyte and human PBL viability. (A) GNP. (B) SNP. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 2. Effects of NP on mouse splenic lymphocyte and human PBL viability. (A) GNP. (B) SNP. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 3. Effects of NP on unstimulated murine splenic lymphocytes and human PBL [3H]-thymidine incorporation. (A) GNP. (B) SNP. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 3. Effects of NP on unstimulated murine splenic lymphocytes and human PBL [3H]-thymidine incorporation. (A) GNP. (B) SNP. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 4. Effects of NP on mitogen-stimulated lymphocyte proliferative response of murine splenic lymphocytes. (A) GNP. (B) SNP. Mean stimulation indices with mitogens: LPS =23 (±1), ConA =25 (±1) are normalized to 100% value. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 4. Effects of NP on mitogen-stimulated lymphocyte proliferative response of murine splenic lymphocytes. (A) GNP. (B) SNP. Mean stimulation indices with mitogens: LPS =23 (±1), ConA =25 (±1) are normalized to 100% value. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 5. Effects of NP on mitogen-stimulated proliferative response of human PBL. (A) GNP. (B) SNP. Mean stimulation indices with mitogens: PHA =58 (±2) and PWM =24 (±1) are normalized to 100% value. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 5. Effects of NP on mitogen-stimulated proliferative response of human PBL. (A) GNP. (B) SNP. Mean stimulation indices with mitogens: PHA =58 (±2) and PWM =24 (±1) are normalized to 100% value. Data shown are means (±SEM) of three experiments. *p < .05, NP treated versus control.

Figure 6. Mitogen-stimulated proliferative responses of lymphocytes cultured in NP-free supernatants obtained from GNP and SNP incubated in complete medium for 72 h. (A) GNP G1 = 50 μg/ml, G2 = 200 μg/ml. (B) SNP: S1 = 12.5 μg/ml, S2 = 50 μg/ml. Mean stimulation indices with mitogens: LPS =22 (±1), ConA =17 (±2), PHA =21 (±1) and PWM =54 (±3) are normalized to 100% value. Data shown are means (±SEM) of three experiments.

Figure 6. Mitogen-stimulated proliferative responses of lymphocytes cultured in NP-free supernatants obtained from GNP and SNP incubated in complete medium for 72 h. (A) GNP G1 = 50 μg/ml, G2 = 200 μg/ml. (B) SNP: S1 = 12.5 μg/ml, S2 = 50 μg/ml. Mean stimulation indices with mitogens: LPS =22 (±1), ConA =17 (±2), PHA =21 (±1) and PWM =54 (±3) are normalized to 100% value. Data shown are means (±SEM) of three experiments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.